EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The First Case of Haemophagocytic Lymphohistiocytosis Triggered by the Booster Dose of Anti-SARS-CoV-2 Vaccine in a Patient with β-Thalassemia

Giuseppina Calvaruso, Marta Chiavetta, Disma Renda, Simona Raso, Francesco Dieli, Vincenzo Luca Lentini, Massimo Gentile, Antonio Carroccio, Aurelio Maggio

Thalassemia Reports · 2022

DOI: 10.3390/thalassrep12020009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thalassemia Reports, 2022. Verfasst von Giuseppina Calvaruso und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Haemophagocytic lymphohistiocytosis (HLH) is a rare and potentially life-threatening systemic hyperinflammatory disease, which can have several aetiologies. Clinical case: a 48-year-old woman affected by a transfusion-dependent β-thalassemia was hospitalized in our haematology unit presenting with intermittent fever, haepatosplenomegaly and pancytopenia, which developed a few days after the booster dose of anti-SARS-CoV-2 mRNA vaccine. The investigations performed during hospitalization led to a diagnosis of HLH and steroid therapy where IV dexamethasone was initiated and provided benefits. Conclusions: the severity of HLH mandates early treatment, but the management of patients with post-vaccine HLH is still challenging and requires further study. No cases of HLH in patients with thalassemia were previously described.

Zitieren

APA

Calvaruso, G., Chiavetta, M., Renda, D., Raso, S., Dieli, F., Lentini, V. L., Gentile, M., Carroccio, A., & Maggio, A. (2022). The First Case of Haemophagocytic Lymphohistiocytosis Triggered by the Booster Dose of Anti-SARS-CoV-2 Vaccine in a Patient with β-Thalassemia. Thalassemia Reports. https://doi.org/10.3390/thalassrep12020009

Vancouver

Calvaruso G, Chiavetta M, Renda D, Raso S, Dieli F, Lentini VL, et al. The First Case of Haemophagocytic Lymphohistiocytosis Triggered by the Booster Dose of Anti-SARS-CoV-2 Vaccine in a Patient with β-Thalassemia. Thalassemia Reports. 2022. doi:10.3390/thalassrep12020009

BibTeX
@article{Calvaruso2022,
  author = {Calvaruso, Giuseppina and Chiavetta, Marta and Renda, Disma and Raso, Simona and Dieli, Francesco and Lentini, Vincenzo Luca and Gentile, Massimo and Carroccio, Antonio and Maggio, Aurelio},
  title = {The First Case of Haemophagocytic Lymphohistiocytosis Triggered by the Booster Dose of Anti-SARS-CoV-2 Vaccine in a Patient with β-Thalassemia},
  journal = {Thalassemia Reports},
  year = {2022},
  doi = {10.3390/thalassrep12020009}
}
Kostenlos starten →